Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Reviews in Endocrine & Metabolic Disorders|June 30, 2011
Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolismThomas Scherer, Christoph BuettnerJournal of Molecular Medicine (Berlin, Germany)|March 18, 2009
The dysregulation of the endocannabinoid system in diabesity-a tricky problemThomas Scherer, Christoph BuettnerNature Reviews. Endocrinology|June 10, 2021
Brain insulin signalling in metabolic homeostasis and diseaseThomas Scherer, Kenichi Sakamoto, Christoph BuettnerEndocrinology and Metabolism Clinics of North America|February 9, 2013
Brain insulin and leptin signaling in metabolic control: from animal research to clinical applicationThomas Scherer, Hendrik Lehnert, Manfred HallschmidSTAR Protocols|February 28, 2023
Measuring VLDL<sub>1</sub> secretion in humans with an intravenous fat emulsion testMatthäus Metz, Clemens Baumgartner, Herbert Stangl, et al.CNS Drugs|June 29, 2026
Impact of Omaveloxolone on Serum Lipids in Patients with Friedreich Ataxia: A 1-Year Real-World AnalysisDominic Buchinger, Thomas Scherer, Daniel Dalos, et al.BMJ Case Reports|June 28, 2017
Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasiaEvelin Kovacs-Sipos, David Holzmann, Thomas Scherer, et al.Orphanet Journal of Rare Diseases|January 16, 2026
Austrian Pompe Outcome Consensus (APOC): a national Delphi studyFlorian B Lagler, Thomas Scherer, Jörg Weber, et al.Diabetes|March 31, 2011
Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysisJames D O'Hare, Elizabeth Zielinski, Bob Cheng, et al.Molecular Metabolism|April 26, 2023
Brain insulin signaling suppresses lipolysis in the absence of peripheral insulin receptors and requires the MAPK pathwayMatthäus Metz, James O'Hare, Bob Cheng, et al.Pageof 10